Arrowhead Pharmaceuticals
ARWR
#1801
Rank
ยฃ8.84 B
Marketcap
ยฃ62.79
Share price
-3.06%
Change (1 day)
423.18%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): ยฃ0.70

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ0.60. In 2025 the company made an earnings per share (EPS) of -ยฃ0.007417 an increase over its 2024 EPS that were of -ยฃ3.71.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.70-9470.15%
2025-ยฃ0.007417-99.8%
2024-ยฃ3.71161.39%
2023-ยฃ1.4217.36%
2022-ยฃ1.2119.85%
2021-ยฃ1.0161.9%
2020-ยฃ0.62-216.67%
2019ยฃ0.53-210.77%
2018-ยฃ0.4838.3%
2017-ยฃ0.35-64.93%
2016-ยฃ0.99-16.25%
2015-ยฃ1.1928%
2014-ยฃ0.93-3.85%
2013-ยฃ0.96-31.58%
2012-ยฃ1.41331.82%
2011-ยฃ0.33-51.11%
2010-ยฃ0.67-79.07%
2009-ยฃ3.19-37.68%
2008-ยฃ5.12-16.87%
2007-ยฃ6.1638.33%
2006-ยฃ4.45122.22%
2005-ยฃ2.0042.11%
2004-ยฃ1.41533.33%
2003-ยฃ0.22-99.08%
2002-ยฃ24.0825%
2001-ยฃ19.2733.33%
2000-ยฃ14.45-120%
1999ยฃ72.25-400%
1998-ยฃ24.08-81.48%
1997-ยฃ130.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.48 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ6.05-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ5.82 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.81 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ1.68-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA